Dr. Galsky describes the OS signal data from CheckMate-274 on adjuvant nivolumab for muscle-invasive bladder cancer. Dr. Matt Galsky, Brian, and Tom discuss the IMvigor011 trial data that was presented at EAU 2024. Betsy Plimack discusses the tricks of the trade for adverse event management. Dr. Ashish Kamat walks through ongoing issues around surgery in urothelial cancer at EAU 2021. Peter Albers talks about exciting updates in prostate cancer research and picks his three highlights from EAU21. Dr. Grant Stewart discusses renal cancer data presented at the 2021 EAU Conference.